Skip to main content

Table 3 Clinical events

From: Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study

Parameter

Placebo (N = 1206)

Apabetalone (N = 1212)

P value

First hospitalization for heart failure, n (%)

48 (4.0)

29 (2.4)

0.03

HR (95% CI)

0.59 (0.38–0.94)

Total hospitalizations for heart failure, n

70

35

0.01

HR (95% CI)

0.47 (0.27–0.83)

Cardiovascular death, n (%)

55 (4.6)

45 (3.7)

0.28

HR (95% CI)

0.81 (0.54–1.19)

First hospitalization for heart failure or cardiovascular death, n (%)

94 (7.8)

69 (5.7)

0.04

HR (95% CI)

0.72 (0.53–0.98)

  1. Cardiovascular events in patients treated with apabetalone or placebo